Keros Therapeutics (KROS) Shareholder's Equity (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | 303.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 303.13 Mn |
| Sep 30, 2025 | 703.58 Mn |
| Jun 30, 2025 | 706.73 Mn |
| Mar 31, 2025 | 728.87 Mn |
| Dec 31, 2024 | 571.55 Mn |
| Sep 30, 2024 | 532.84 Mn |
| Jun 30, 2024 | 420.92 Mn |
| Mar 31, 2024 | 453.95 Mn |
| Dec 31, 2023 | 332.21 Mn |
| Sep 30, 2023 | 295.84 Mn |
| Jun 30, 2023 | 326.26 Mn |
| Mar 31, 2023 | 354.98 Mn |
| Dec 31, 2022 | 277.42 Mn |
| Sep 30, 2022 | 241.03 Mn |
| Jun 30, 2022 | 211.21 Mn |
| Mar 31, 2022 | 223.49 Mn |
| Dec 31, 2021 | 243.17 Mn |
| Sep 30, 2021 | 218.48 Mn |
| Jun 30, 2021 | 235.66 Mn |
| Mar 31, 2021 | 248.37 Mn |
| Dec 31, 2020 | 261.72 Mn |
| Sep 30, 2020 | 130.76 Mn |
| Jun 30, 2020 | 141.36 Mn |
| Mar 31, 2020 | -24.87 Mn |
| Dec 31, 2019 | -19.45 Mn |
| Sep 30, 2019 | -16.72 Mn |
| Jun 30, 2019 | -13.19 Mn |
| Mar 31, 2019 | -10.36 Mn |